Next Article in Journal
Methylliberine Ingestion Improves Various Indices of Affect but Not Cognitive Function in Healthy Men and Women
Next Article in Special Issue
Anti-Fibrosis Effect of Panax ginseng and Inula japonica Formula in Human Pulmonary Fibroblasts
Previous Article in Journal
Under-Fuelling for the Work Required? Assessment of Dietary Practices and Physical Loading of Adolescent Female Soccer Players during an Intensive International Training and Game Schedule
Previous Article in Special Issue
A Naturally Derived Watercress Flower-Based Phenethyl Isothiocyanate-Enriched Extract Induces the Activation of Intrinsic Apoptosis via Subcellular Ultrastructural and Ca2+ Efflux Alterations in an In Vitro Model of Human Malignant Melanoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 15
Issue 21
10.3390/nu15214510
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Hypotensive and Vasorelaxant Effects of Sanguisorbae Radix Ethanol Extract in Spontaneously Hypertensive and Sprague Dawley Rats

by
Jaesung Jung
1,†,
Sujin Shin
1,†,
Junkyu Park
2,
Kyungjin Lee
3,* and
Ho-Young Choi
3,*
1
Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea
2
Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea
3
Department of Herbal Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2023, 15(21), 4510; https://doi.org/10.3390/nu15214510
Submission received: 5 October 2023 / Revised: 21 October 2023 / Accepted: 23 October 2023 / Published: 24 October 2023
(This article belongs to the Special Issue Nutritional Regulation of Plant Extracts on Human Health)
Browse Figures
Versions Notes

Abstract

:
Hypertension requires proper management because of the increased risk of cardiovascular disease and death. For this purpose, functional foods containing tannins have been considered an effective treatment. Sanguisorbae radix (SR) also contains various tannins; however, there have been no studies on its vasorelaxant or antihypertensive effects. In this study, the vasorelaxant effect of the ethanol extract of SR (SRE) was investigated in the thoracic aorta of Sprague Dawley rats. SRE (1, 3, 10, 30, and 100 μg/mL) showed this effect in a dose-dependent manner, and its mechanisms were related to the NO/cGMP pathway and voltage-gated K+ channels. Concentrations of 300 and 1000 μg/mL blocked the influx of extracellular Ca2+ and inhibited vasoconstriction. Moreover, 100 μg/mL of SRE showed a relaxing effect on blood vessels constricted by angiotensin II. The hypotensive effect of SRE was investigated in spontaneously hypertensive rats (SHR) using the tail-cuff method. Blood pressure significantly decreased 4 and 8 h after 1000 mg/kg of SRE administration. Considering these hypotensive effects and the vasorelaxant mechanisms of SRE, our findings suggests that SRE can be used as a functional food to prevent and treat hypertension. Further studies are needed for identifying the active components and determining the optimal dosage.

Graphical Abstract

1. Introduction

Hypertension has a worldwide prevalence of about 30% and requires management because of the increased risk of cardiovascular disease and death [1]. However, among patients receiving hypertension treatment, the rate of maintaining normal blood pressure is very low, at approximately 20% [2]. In addition, taking high blood pressure medications may cause side effects such as dizziness and palpitation [3] and increase the risk of hyperuricemia and gout [4]. Therefore, it is necessary to investigate alternative treatment methods to manage high blood pressure, including functional food and herbs [5,6,7,8].
Sanguisorba officinalis Linné is a plant belonging to the Rosaceae family and grows abundantly in Asia, Europe, and North America [9]. Young leaves and flower buds are eaten in salads, and the roots have long been used as herbs for the treatment of bleeding, internal hemorrhage, melena, burn, and dermatitis in the Republic of Korea, Japan, and China [10]. Sanguisorbae radix (SR), the root of Sanguisorba officinalis, has been used for its hemostatic effects [11], and many studies have described its anti-inflammatory [12], antioxidant [13], anti-cancer [14], and antidiabetic [15] effects.
The main components of SR are tannins [16], which have been primarily analyzed for their anticancer activity [17]. Studies have shown that tannins extracted from other plants act as vascular relaxants [18] and are effective in treating high blood pressure by inhibiting angiotensin-converting enzymes [19]. However, to the best of our knowledge, there are no studies on SR as a vascular relaxant or antihypertensive.
Therefore, we investigated the vasorelaxant effect and its mechanism of the ethanol extract of SR (SRE) in the thoracic aortic ring of Sprague Dawley (SD) rats contracted with phenylephrine (PE) in this study. In addition, the hypotensive effects of SRE were investigated by measuring the blood pressure of spontaneously hypertensive rats (SHR) before and after SRE administration.

2. Materials and Methods

2.1. Materials and Chemicals

PE, acetylcholine (ACh), methylene blue (MB), indomethacin, ethyleneglycol-bis(2-aminoethylether)-N,N‚N′,N′-tetraacetic acid (EGTA), and angiotensin II (Ang II) were purchased from Sigma Aldrich (ST. Louis, MA, USA). 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) was purchased from Tokyo Chemical Industry (Tokyo, Japan). NG-nitro-L-arginine methyl ester (L-NAME), 4-aminopyridine (4-AP), glibenclamide, and tetraethylammoniumchloride (TEA) were purchased from Wako Pure Chemical Industries (Osaka, Japan). Barium chloride (BaCl2), glucose, magnesium sulfate (MgSO4), monobasic potassium phosphate (KH2PO4), potassium chloride (KCl), sodium chloride (NaCl), sodium hydrogen carbonate (NaHCO3), calcium chloride (CaCl2), and urethane were purchased from Daejeong Chemical & Gold (Siheung-si, Republic of Korea). Dimethyl sulfoxide (DMSO) was purchased from Junsei (Tokyo, Japan), and ethanol was purchased from Duksan Pharmaceutical Co., Ltd. (Ansan-si, Republic of Korea).

2.2. Sample Preparation

Sanguisorba officinalis L. was collected in Pyeongchang-gun, Gangwon-do, Republic of Korea, in October 2021. Subsequent to the collection, morphological identification was performed by Professor Weon-Ki Paik, affiliated with the division of Life Science & Chemistry at Daejin University, and by Kang-Hyup Lee from the division of Forest Biodiversity at the Korea National Arboretum. To ascertain genetic identification, a comprehensive comparison of ITS, matK, and rbcL DNA barcodes was undertaken. The voucher specimen of Sanguisorba officinalis L. was deposited at the College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea. The root was naturally dried in a well-ventilated and shaded environment. A 10-fold amount (300 mL) of 50% ethanol was added to the dried SR (30 g), and extraction was performed by boiling at a consistent temperature of 70 ± 2 °C for 2 h. SRE was filtered twice with a qualitative filter paper (Hyundai micro, No. 2), freeze-dried, and stored in a −20 °C refrigerator. The extract yield was 23.3%. SRE was dissolved in DMSO and used in the experiments.

2.3. Animals

Male SD rats, weighing between 230 and 250 g and aged between 6 and 7 weeks (sourced from Daehan Biolink, Eumseong-gun, Republic of Korea), along with male SHR, weighing between 450 and 500 g and aged 1.5 years (sourced from SLC, Inc., Shizuoka, Japan), were employed in the study. The SHRs were randomly allocated to either the control group or the SRE administration group. The animals utilized in the experiments were accommodated in an environment maintained at a room temperature of 22 ± 2 °C, subjected to a 12/12 h light/dark cycle. Both feed and tap water were provided ad libitum. All experiments complied with the Animal Welfare Guidelines of the Animal Experiment Ethics Committee of Kyung Hee University and were approved by the committee (KHSASP-23-066).

2.4. Measurement of Isotonic Changes in Blood Vessels

2.4.1. Preparation of Rat Aortic Rings

SD rats were anesthetized by intraperitoneal injection of urethane (1.2 g/kg), and the thoracic aorta was isolated. The isolated aorta was transferred to a Petri dish containing Krebs–Henseleit (KH) buffer composed of 118.0 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, and 25.0 mM NaHCO3. The connective tissue and fat surrounding the aorta were removed immediately, and it was cut into several 2–3 mm long segments. The cut aortic rings were hung between tungsten hooks in an organ bath containing 10 mL of KH buffer. A mixed gas of 95% O2 and 5% CO2 was continuously supplied and the organ bath was maintained at 37 °C. Changes in the isotonic contraction of blood vessels were recorded using PowerLab (AD Instrument Co., Bella Vista, Australia). The rings were stabilized in the organ bath for 40 min and were loaded with a passive tension of 1.0 g. During the equilibration period, the KH buffer in the organ bath was replaced with fresh KH buffer every 5–10 min.

2.4.2. Vasodilatory Effect of SRE on the Rat Aortic Rings Constricted by PE

Thoracic aortic rings were pre-constricted with PE (1 μM) after the equilibration period to evaluate the vasodilatory effect of SRE. After reaching the maximal constriction and achieving equilibrium, SRE was added to the organ bath at cumulative concentrations (1, 3, 10, 30, and 100 μg/mL).

2.4.3. Vasodilatory Effect of SRE on Endothelium-Intact and -Removed Aortic Rings

Thoracic aortic rings were pre-constricted with PE (1 μM) and then were relaxed with ACh (10 μM) to identify vascular endothelial cells. More than 85% relaxation by ACh was confirmed to have no endothelial damage, and aortic rings with less than 10% relaxation were confirmed to have no endothelium. After confirming the integrity of endothelial cells, the thoracic aortic rings were washed with KH buffer several times and constricted again with PE (1 μM).

2.4.4. Vasodilatory Effect of SRE When Pretreated with L-NAME and Indomethacin

Following pretreatment with L-NAME (NO synthase inhibitor, 100 μM) and indomethacin (COX inhibitor, 10 μM) for 20 min, thoracic aortic rings were contracted with PE (1 μM), and then, SRE was administered at cumulative concentrations (1, 3, 10, 30, and 100 μg/mL).

2.4.5. Vasodilatory Effect of SRE When Pretreated with ODQ and MB

After being pretreated with ODQ (sGC inhibitor, 10 μM) and MB (cGMP inhibitor, 10 μM) for 20 min, the aortic vessels were contracted with PE (1 μM), and then, SRE was administered at cumulative concentrations (1, 3, 10, 30, and 100 μg/mL).

2.4.6. Vasodilatory Effect of SRE When Pretreated with K+ Channel Blockers

Pretreatment of vessels with BaCl2 (inward rectifier K+ channel blocker, 10 μM), 4-AP (voltage-dependent K+ channel blocker, 1 mM), TEA (Ca2+-dependent K+ channel blocker, 1 mM), and glibenclamide (ATP-dependent K+ channel blocker, 10 μM) was carried out for 20 min. After pretreatment, thoracic aortic rings were contracted with PE (1 μM), and then SRE was administered at cumulative concentrations (1, 3, 10, 30, and 100 μg/mL).

2.4.7. Inhibitory Effect of SRE on Extracellular Ca2+-Induced Contraction

The aortic rings were stabilized in Ca2+-free KH buffer containing EGTA (1 mM) and were pre-incubated with SRE (100, 300 and 1000 μg/mL) for 20 min. Following PE (1 μM) treatment for 20 min, CaCl2 (0.1, 0.3, 1, 3, 10 mM) was sequentially introduced. The inhibitory effect of SRE on vasoconstriction induced by Ca2+ channels was compared to that of the control group without SRE.

2.4.8. Inhibitory Effect of SRE on Ang II-Induced Contraction

The aortic rings were stabilized in KH buffer and then pre-incubated with SRE (100 μg/mL) for 20 min. Ang II was administered at cumulative concentrations (10−9–10−6 M), and the inhibitory effect of SRE on vasoconstriction induced by Ang II was compared to that of the control group without SRE.

2.5. Blood Pressure Measurement of SHR

The systolic blood pressure (SBP) and diastolic blood pressure (DBP) of the SHR were measured using the tail-cuff method (CODA 8-Channel High Throughput Non-Invasive Blood Pressure System, Kent Scientific Co., Torrington, CT, USA). SRE (300 mg/kg and 1000 mg/kg per dose) was administered orally to the SHR. SBP and DBP were measured before and 1, 2, 4, and 8 h after drug administration and then compared with the control group (administered distilled water instead of SRE).

2.6. Statistical Analysis

All statistical analyses were performed using an unpaired t-test and two-way ANOVA using GraphPad Prism 9 software (San Diego, CA, USA). Bonferroni’s multiple comparison test was used for post hoc analysis. The experimental data were presented as the mean ± standard error of the mean (SEM). Statistical significance was confirmed at p < 0.05.

3. Results

3.1. Vasodilatory Effect of SRE on the Aortic Rings Constricted by PE

Aortic rings were constricted with PE (1 μM) and treated with SRE (1, 3, 10, 30, and 100 μg/mL). The resulting vasorelaxant effect occurred in a concentration-dependent manner compared to the control (Figure 1). SRE at 100 μg/mL showed a maximum effect of 74.81 ± 3.00% on PE-constricted aortic rings.

3.2. Vasodilatory Effect of SRE on Endothelium-Intact and -Removed Aortic Rings

Endothelium-intact and -removed aortic rings were compared with each control group to confirm whether the vasorelaxant effect of SRE was related to endothelial cells. In the presence of the endothelium cells, SRE acted as a vasorelaxant in a concentration-dependent manner, with a maximum effect of 93.18 ± 4.20% at 100 μg/mL (Figure 2A,B). However, in the absence of cells, no significant changes were observed until the dose reached 300 μg/mL. Maximum relaxation was observed after treatment with 1000 μg/mL of SRE (Figure 2C,D).

3.3. Effects of L-NAME and Indomethacin Pretreatment on Vasorelaxation

Thoracic aortic rings were pretreated with L-NAME (100 μM) and indomethacin (10 μM), and the vasorelaxant effect of SRE (1, 3, 10, 30, and 100 μg/mL) was compared with that of the control (without pretreatment) group. Pretreatment with L-NAME significantly suppressed the vasorelaxant effect of SRE (Figure 3). However, pretreatment with indomethacin showed no significant difference with the control group (Figure 3).

3.4. Effects of ODQ and MB Pretreatment on Vasorelaxation

Thoracic aortic rings were pretreated with ODQ (10 μM) and MB (10 μM), and the vasorelaxant effect of SRE (1, 3, 10, 30, and 100 μg/mL) was compared with that of the control (without pretreatment) group. The vasodilatory effect was significantly suppressed in aortic rings pretreated with ODQ and MB compared to the control group (Figure 4).

3.5. Effect of K+ Channel Blocker Pretreatment on Vasorelaxation

Thoracic aortic rings were pretreated with K+ channel blockers: BaCl2 (10 μM), 4-AP (1 mM), TEA (1 mM), and glibenclamide (10 μM). The vasorelaxant effect of SRE (1, 3, 10, 30, and 100 μg/mL) was compared with that of the control (without pretreatment) group. The group pretreated with BaCl2, glibenclamide, and TEA showed no significant differences compared to the control group, but the vasorelaxant effect of SRE was significantly suppressed by pretreatment with 4-AP (Figure 5).

3.6. Inhibitory Effect of SRE on Extracellular Ca2+-Induced Contraction

Thoracic aortic rings were pretreated with SRE (100, 300, and 1000 μg/mL), and CaCl2 (0.1, 0.3, 1, 3, and 10 mM) was administered for gradual contraction. No significant differences were observed between the group treated with 100 µg/mL of SRE and the non-treated control group (Figure 6). However, 300 and 1000 µg/mL of SRE showed inhibitory effect on Ca2+-induced contraction compared to the non-treated control group.

3.7. Inhibitory Effect of SRE on Angiotensin II-Induced Contraction

Thoracic aortic rings were pretreated with 100 µg/mL of SRE, and Ang II was administered at cumulative concentrations (10−9, 10−8, 10−7, and 10−6 M). Consequently, 100 µg/mL of SRE inhibited Ang II-induced contractions compared to the control group (Figure 7).

3.8. Blood Pressure-Lowering Effect of SRE

To investigate the blood pressure-lowering effect of SRE, SBP and DBP were measured at 1, 2, 4, and 8 h after the oral administration of 300 or 1000 mg/kg of SRE to SHR. The measured SBP and DBP values were compared with the control group. Because of pre-existing differences in blood pressure in individual SHRs, the difference before and after administration was calculated and was compared with the control group. The SBP and DBP values significantly decreased 4 and 8 h after the administration of 1000 mg/kg of SRE (Figure 8).

4. Discussion

In the present study, we evaluated the vasorelaxant and hypotensive effects of SRE. The vasorelaxant effect and its mechanism of action were investigated using dissected thoracic aorta of SD rats constricted with PE. Our results showed that SRE relaxed the PE-constricted thoracic aortic rings in a concentration-dependent manner compared to the control group. Various factors affect vasodilation. Among them, vascular endothelial cells play a crucial role in regulating vascular relaxation and contraction, thereby maintaining circulatory homeostasis [20]. To determine whether endothelial cells are involved in the vascular relaxation of SRE, the vasodilatory effect was evaluated by administering SRE on thoracic aortic rings with and without endothelial cells. The experimental results showed that SRE (1, 3, 10, 30, and 100 μg/mL) relaxed PE-constricted thoracic aortic rings with endothelium in a concentration-dependent manner. However, in the experiment in which the endothelium was removed, no significant effect was seen at concentrations below 300 µg/mL, whereas vascular relaxation was observed at a concentration of 1000 µg/mL. These results indicate that SRE has an endothelium-dependent vasorelaxant effect at low concentrations (below 300 µg/mL) and has an additional vasorelaxant effect through an endothelium unrelated mechanism at higher concentrations.
NO and PGI2 are released from endothelial cells and cause VSMC relaxation [21]. NO is produced from L-arginine by NO synthase, and PGI2 is produced from arachidonic acid by COX [21]. To study the mechanism of action of SRE in vascular endothelial cells, thoracic aortic sections were pretreated with L-NAME (an NO synthase inhibitor) and indomethacin (a COX inhibitor), and contraction was induced with PE. In our study, the vasorelaxant effect was significantly reduced in the aortic rings pretreated with L-NAME; however, there was no significant difference compared to the control in the aortic rings with indomethacin pretreatment. Therefore, our results indicate that the vasorelaxant effect of SRE is not related to PGI2 but is related to NO.
The NO produced in vascular endothelial cells activates sGC in VSMC and increases cGMP concentration [22]; consequently, Ca2+ in VSMC decreases, causing blood vessels to relax [21]. To determine whether SRE acts on the NO/cGMP pathway, the thoracic aortic rings were pretreated with ODQ (an sGC inhibitor) or MB (a cGMP inhibitor). In our study, pretreatment with ODQ and MB significantly reduced the vasorelaxant effect, indicating that SRE relaxes blood vessels through the NO/cGMP pathway in vascular endothelial cells.
K+ channels are important regulators of VSMC [23]. When K+ channels are activated, K+ efflux increases and the activity of voltage-dependent Ca2+ channels is reduced, thereby reducing the intracellular Ca2+ concentration [24]. To study the mechanism of action of SRE on K+ channels, thoracic aortic sections were pretreated with BaCl2 (an inward rectifier K+ channel blocker), 4-AP (a voltage-dependent K+ channel blocker), TEA (a Ca2+-dependent K+ channel blocker), or glibenclamide (an ATP-dependent K+ channel blocker), and the vasorelaxant effects were compared to those in the control group. The BaCl2, TEA, and glibenclamide pretreatments did not affect the vasorelaxant effect of SRE; however, 4-AP pretreatment significantly inhibited it. These results indicated that the vasorelaxant effect of SRE is related to voltage-gated K+ channels (Kv).
Ca2+ channels are also important mechanisms that regulate the contraction and relaxation of VSMC. When intracellular Ca2+ concentration increases, actin–myosin interactions increase, leading to VSMC constriction [25]. To investigate whether SRE activity is related to Ca2+ channels, the thoracic aortic rings were pretreated with SRE in a Ca2+-free KH buffer. The thoracic aortic rings were then constricted with PE, and CaCl2 was administered cumulatively (0.1, 0.3, 1, 3, and 10 mM). In our experiment, there was no significant difference between the 100 µg/mL SRE group and the non-treated control group. However, SRE concentrations of 300 and 1000 µg/mL showed significant difference from the control group. This suggests that SRE inhibits constriction via extracellular Ca2+ influx at high doses (300 and 1000 µg/mL).
Furthermore, Ang II, which is produced in the vascular wall, is also involved in regulating vascular tone [26]. Ang II induces vasoconstriction by increasing intracellular Ca2+ concentrations, and the dysregulation of Ang II contributes to the development of hypertension [27]. To investigate whether SRE activity affects Ang II, the thoracic aortic rings were pretreated with 100 µg/mL of SRE and Ang II was administered cumulatively (10−9–10−6 M). Consequently, SRE significantly reduced the degree of contractility induced by Ang II, proving its inhibitory effect on the peptide.
To determine whether SRE is effective in treating high blood pressure in vivo, SBP and DBP were measured 1, 2, 4, and 8 h after oral administration of SRE (300 or 1000 mg/kg) in SHR. After 4 and 8 h of SRE 1000 mg/kg of SRE, SBP and DBP significantly decreased. When converting the dose administered to animals (300 mg/kg–1000 mg/kg) to the human equivalent, approximately 3–10 g of SRE can be added to an adult male weighing 60 kg [28]. SRE has long been used in traditional medicine for its hemostatic effects [11]. In general, natural products used in traditional medicine in east Asia showed a wide range of therapeutic dosage (e.g., 4–80 g) and toxicities were known to be low [29]. However, further investigation and toxicity evaluation are required to determine the optimal administration dosage.
The prevalence of high blood pressure increases with age and is accompanied by endothelial cell damage [30]. Therefore, it is important to determine whether it lowers blood pressure in older adults. In our study, the SHR were older (1.5 years old), and it was assumed that their vascular endothelial cells were impaired [31]. Because SRE has a vasorelaxant effect through various mechanisms as well as an endothelium-related relaxation mechanism, it appears to be effective in lowering blood pressure in older SHR. Considering these results, SRE could be used for the prevention and treatment of high blood pressure.
According to a previous study, SRE has bioactive compounds belonging to tannins, flavonoids, and phenolic acids [32]. In particular, SRE is widely known to be rich in tannins, primarily hydrolysable ellagitannins and gallotanins, such as sanguiin H-1, sanguiin H-2, sanguiin H-6, and sanguiin H-10 [33]. Tannins extracted from other plants showed vasorelaxant and hypotensive effects; the tannin components of SRE are presumed to have the chief vasodilatory effect [18,19]. However, bioactive compounds in SRE were not analyzed in this study. Additional research is needed to identify the representative components in SRE that exhibit vasorelaxant and blood pressure-lowering effects.
As high blood pressure becomes increasingly prevalent, research is being continued to investigate methods for blood pressure management through food or plants. Studies showed that the vasodilatory effect of plant and natural products were mainly correlated with the NO/cGMP pathway or blockage of the Ca2+ channel [34]. Some natural products, such as anthocyanin-rich sour cherries [6] and Prunus Persica branches [35] showed endothelial-dependent vasorelaxation via the NO/cGMP pathway; other compounds, such as the persimmon-derived polyphenol phytocomplex [36] and scutellarin extracted from Erigeron breviscapus [37] showed vasorelaxation via the Ca2+ channel. Therefore, SRE appears to have an advantage over other foods or plants because it exhibits vascular relaxant effect via various mechanisms.

5. Conclusions

In conclusion, SRE activated the NO/cGMP pathway and blocked voltage-gated K+ channels (Kv) to relax constricted blood vessels. At high concentrations, SRE blocked the influx of extracellular Ca2+ and inhibited blood vessel constriction. Moreover, SRE had a relaxing effect on blood vessels constricted by Ang II. The SBP and DBP of elderly SHR significantly decreased 4 and 8 h after administering 1000 mg/kg of SRE. Considering these vascular relaxation mechanisms and the hypotensive effect of SRE, our findings suggest that SRE can be used as a functional food to prevent and treat hypertension. However, more extensive research is imperative for further applications of SRE, including identifying its constituents and active components, determining the optimal dosage for administration, and evaluating its toxicity.

Author Contributions

Conceptualization, K.L. and H.-Y.C.; methodology, J.J. and H.-Y.C.; software, S.S.; formal analysis, S.S. and J.P.; investigation, J.J. and S.S.; resources, K.L. and H.-Y.C.; data curation, S.S. and J.P.; writing—original draft preparation, J.J. and S.S.; writing—review and editing, K.L. and H.-Y.C.; supervision, H.-Y.C. All authors have read and agreed to the published version of the manuscript.

Funding

This study received no external funding.

Institutional Review Board Statement

This study was approved by the Institutional Animal Care and Use Committee of Kyung Hee University (KHSASP-23-340).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available from the corresponding author upon request.

Acknowledgments

The authors are grateful for the help of Weon-Ki Paik and Kang-Hyup Lee in the morphological identification of the SR.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mills, K.T.; Bundy, J.D.; Kelly, T.N.; Reed, J.E.; Kearney, P.M.; Reynolds, K.; Chen, J.; He, J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation 2016, 134, 441–450. [Google Scholar] [CrossRef] [PubMed]
  2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021, 398, 957–980. [Google Scholar] [CrossRef]
  3. Olsen, H.; Klemetsrud, T.; Stokke, H.P.; Tretli, S.; Westheim, A. Adverse drug reactions in current antihypertensive therapy: A general practice survey of 2586 patients in Norway. Blood Press. 1999, 8, 94–101. [Google Scholar]
  4. Jiao, X.-F.; Song, K.; Jiao, X.; Li, H.; Zeng, L.; Zou, K.; Zhang, W.; Wang, H.; Zhang, L. Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system. Front. Pharmacol. 2023, 13, 1045561. [Google Scholar] [CrossRef]
  5. Lee, S.; Jo, C.; Choi, H.-Y.; Lee, K. Effect of Co-Administration of Curcumin with Amlodipine in Hypertension. Nutrients 2021, 13, 2797. [Google Scholar] [CrossRef]
  6. Markovics, A.; Biro, A.; Kun-Nemes, A.; Fazekas, M.É.; Rácz, A.A.; Paholcsek, M.; Lukács, J.; Stündl, L.; Remenyik, J. Effect of Anthocyanin-Rich Extract of Sour Cherry for Hyperglycemia-Induced Inflammatory Response and Impaired Endothelium-Dependent Vasodilation. Nutrients 2020, 12, 3373. [Google Scholar] [CrossRef]
  7. Alsayed, A.M.A.; Zhang, B.L.; Bredeloux, P.; Boudesocque-Delaye, L.; Yu, A.; Peineau, N.; Enguehard-Gueiffier, C.; Ahmed, E.M.; Pasqualin, C.; Maupoil, V. Aqueous Fraction from Hibiscus sabdariffa Relaxes Mesenteric Arteries of Normotensive and Hypertensive Rats through Calcium Current Reduction and Possibly Potassium Channels Modulation. Nutrients 2020, 12, 1782. [Google Scholar] [CrossRef]
  8. Nakamura, K.; Suzuki, Y.; Goto, K.; Yamaguchi, S.; Hiramitsu, M. Antihypertensive and Vasorelaxant Effects of Citric Acid and Lemon Juice in Spontaneously Hypertensive Rats: In Vivo and Ex Vivo Studies. Nutrients 2023, 15, 3849. [Google Scholar] [CrossRef]
  9. Ishimaru, K.; Hirose, M.; Takahashi, K.; Koyama, K.; Shimomura, K. Sanguisorba officinalis L. (Great Burnet): In Vitro Culture and Production of Sanguiin, Tannins, and Other Secondary Metabolites. In Medicinal and Aromatic Plants VIII, 1st ed.; Bajaj, Y.P.S., Ed.; Springer: Berlin, Germany, 1995; Volume 33, pp. 427–441. [Google Scholar]
  10. Bączek, K. Accumulation of biomass and phenolic compounds in Polish and Mongolian great burnet (Sanguisorba officinalis L.) populations. Herba Pol. 2014, 60, 44–55. [Google Scholar] [CrossRef]
  11. Zhou, P.; Li, J.; Chen, Q.; Wang, L.; Yang, J.; Wu, A.; Jiang, N.; Liu, Y.; Chen, J.; Zou, W.; et al. A Comprehensive Review of Genus Sanguisorba: Traditional Uses, Chemical Constituents and Medical Applications. Front. Pharmacol. 2021, 12, 750165. [Google Scholar] [CrossRef]
  12. Yu, T.; Lee, Y.J.; Yang, H.M.; Han, S.; Kim, J.H.; Lee, Y.; Kim, C.; Han, M.H.; Kim, M.-Y.; Lee, J.; et al. Inhibitory effect of Sanguisorba officinalis ethanol extract on NO and PGE2 production is mediated by suppression of NF-κB and AP-1 activation signaling cascade. J. Ethnopharmacol. 2011, 134, 11–17. [Google Scholar] [CrossRef]
  13. Nam, Y.; Kim, M.; Erdenebileg, S.; Cha, K.H.; Ryu, D.H.; Kim, H.Y.; Lee, S.H.; Jung, J.H.; Nho, C.W. Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice. Nutrients 2023, 15, 3779. [Google Scholar] [CrossRef]
  14. Wang, Z.; Loo, W.T.; Wang, N.; Chow, L.W.; Wang, D.; Han, F.; Zheng, X.; Chen, J.-P. Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis. Expert. Opin. Ther. Targets 2012, 16 (Suppl. S1), S79–S89. [Google Scholar] [CrossRef]
  15. Son, D.J.; Hwang, S.Y.; Kim, M.-H.; Park, U.K.; Kim, B.S. Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice. Nutrients 2015, 7, 5469–5483. [Google Scholar] [CrossRef]
  16. Tu, J.; Li, Q.; Zhou, B. The Tannins from Sanguisorba officinalis L. (Rosaceae): A Systematic Study on the Metabolites of Rats Based on HPLC-LTQ-Orbitrap MS2 Analysis. Molecules 2021, 26, 4053. [Google Scholar] [CrossRef]
  17. Li, W.; Yang, C.-J.; Wang, L.-Q.; Wu, J.; Dai, C.; Yuan, Y.-M.; Li, G.Q.; Yao, M.-C. A tannin compound from Sanguisorba officinalis blocks Wnt/β-catenin signaling pathway and induces apoptosis of colorectal cancer cells. Chin. Med. 2019, 14, 22. [Google Scholar] [CrossRef]
  18. Russell, J.A.; Rohrbach, M.S. Tannin induces endothelium-dependent contraction and relaxation of rabbit pulmonary artery. Am. Rev. Respir. Dis. 1989, 139, 498–503. [Google Scholar] [CrossRef]
  19. Liu, J.-C.; Hsu, F.-L.; Tsai, J.-C.; Chan, P.; Liu, J.Y.-H.; Thomas, G.N.; Tomlinson, B.; Lo, M.-Y.; Lin, J.-Y. Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme. Life Sci. 2003, 73, 1543–1555. [Google Scholar] [CrossRef]
  20. Ando, J.; Kamiya, A. Blood flow and vascular endothelial cell function. Front. Med. Biol. Eng. 1993, 5, 245–264. [Google Scholar]
  21. Stankevicius, E.; Kevelaitis, E.; Vainorius, E.; Simonsen, U. Role of nitric oxide and other endothelium-derived factors. Medicina 2003, 39, 333–341. [Google Scholar]
  22. Sharma, V.; Berkelhamer, S.; Lakshminrusimha, S. Persistent pulmonary hypertension of the newborn. Matern. Health Neonatol. Perinatol. 2015, 1, 14. [Google Scholar] [CrossRef]
  23. Michelakis, E.D.; Reeve, H.L.; Huang, J.M.; Tolarova, S.; Nelson, D.P.; Weir, E.K.; Archer, S.L. Potassium channel diversity in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 1997, 75, 889–897. [Google Scholar] [CrossRef]
  24. Nieves-Cintrón, M.; Syed, A.U.; Nystoriak, M.A.; Navedo, M.F. Regulation of voltage-gated potassium channels in vascular smooth muscle during hypertension and metabolic disorders. Microcirculation 2018, 25, e12423. [Google Scholar] [CrossRef]
  25. Touyz, R.M.; Alves-Lopes, R.; Rios, F.J.; Camargo, L.L.; Anagnostopoulou, A.; Arner, A.; Montezano, A.C. Vascular smooth muscle contraction in hypertension. Cardiovasc. Res. 2018, 114, 529–539. [Google Scholar] [CrossRef]
  26. Cat, A.N.D.; Touyz, R.M. Cell signaling of angiotensin II on vascular tone: Novel mechanisms. Curr. Hypertens. Rep. 2011, 13, 122–128. [Google Scholar]
  27. Biancardi, V.C.; Bomfim, G.F.; Reis, W.L.; Al-Gassimi, S.; Nunes, K.P. The interplay between Angiotensin II, TLR4 and hypertension. Pharmacol. Res. 2017, 120, 88–96. [Google Scholar] [CrossRef]
  28. Nair, A.B.; Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic. Clin. Pharm. 2016, 7, 27–31. [Google Scholar] [CrossRef]
  29. Zhonghua Bencao Edit Committee. Zhonghua Bencao; Shanghai Science and Technology Publications: Shanghai, China, 1999. [Google Scholar]
  30. Higashi, Y.; Kihara, Y.; Noma, K. Endothelial dysfunction and hypertension in aging. Hypertens. Res. Off. J. Jpn. Soc. Hypertens. 2012, 35, 1039–1047. [Google Scholar] [CrossRef]
  31. Hongo, K.; Nakagomi, T.; Kassell, N.F.; Sasaki, T.; Lehman, M.; Vollmer, D.G.; Tsukahara, T.; Ogawa, H.; Torner, J. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke 1988, 19, 892–897. [Google Scholar] [CrossRef]
  32. Moţoc, A.-C.T.; Ranga, F.; Teodorescu, A.G.; Pallag, A.; Vlad, A.M.; Bandici, L.; Vicas, S.I. Evaluation of Polyphenolic Composition and Antimicrobial Properties of Sanguisorba officinalis L. and Sanguisorba minor Scop. Plants 2022, 11, 3561. [Google Scholar]
  33. Gawron-Gzella, A.; Witkowska-Banaszczak, E.; Bylka, W.; Dudek-Makuch, M.; Odwrot, A.; Skrodzka, N. Chemical Composition, Antioxidant and Antimicrobial Activities of Sanguisorba officinalis L. Extracts. Pharm. Chem. J. 2016, 50, 244–249. [Google Scholar] [CrossRef] [PubMed]
  34. Tang, F.; Yan, H.-L.; Wang, L.-X.; Xu, J.-F.; Peng, C.; Ao, H.; Tan, Y.-Z. Review of Natural Resources With Vasodilation: Traditional Medicinal Plants, Natural Products, and Their Mechanism and Clinical Efficacy. Front. Pharmacol. 2021, 12, 627458. [Google Scholar] [CrossRef] [PubMed]
  35. Kim, B.; Kim, K.-W.; Lee, S.; Jo, C.; Lee, K.; Ham, I.; Choi, H.-Y. Endothelium-Dependent Vasorelaxant Effect of Prunus persica Branch on Isolated Rat Thoracic Aorta. Nutrients 2019, 11, 1816. [Google Scholar] [CrossRef] [PubMed]
  36. Kudo, R.; Yuui, K.; Kasuda, S. Endothelium-Independent Relaxation of Vascular Smooth Muscle Induced by Persimmon-Derived Polyphenol Phytocomplex in Rats. Nutrients 2021, 14, 89. [Google Scholar] [CrossRef] [PubMed]
  37. Pan, Z.; Feng, T.; Shan, L.; Cai, B.; Chu, W.; Niu, H.; Lu, Y.; Yang, B. Scutellarin-induced endothelium-independent relaxation in rat aorta. Phytother Res. 2008, 22, 1428–1433. [Google Scholar] [CrossRef]
Nutrients 15 04510 g001
Figure 1. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-constricted with phenylephrine (PE, 1 μM). (A) Cumulative concentration–response curves and (B) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4–5). *** p < 0.001 vs. control.
Figure 1. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-constricted with phenylephrine (PE, 1 μM). (A) Cumulative concentration–response curves and (B) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4–5). *** p < 0.001 vs. control.
Nutrients 15 04510 g001
Nutrients 15 04510 g002
Figure 2. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on endothelium-intact [E(+)] or endothelium-removed [E(−)] rat thoracic aortic rings pre-constricted with phenylephrine (PE, 1 μM). (A,C) Cumulative concentration-response curves and (B,D) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4). *** p < 0.001 vs. control.
Figure 2. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on endothelium-intact [E(+)] or endothelium-removed [E(−)] rat thoracic aortic rings pre-constricted with phenylephrine (PE, 1 μM). (A,C) Cumulative concentration-response curves and (B,D) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4). *** p < 0.001 vs. control.
Nutrients 15 04510 g002
Nutrients 15 04510 g003
Figure 3. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-incubated with NG-nitro-L-arginine methyl ester (L-NAME, 100 μM) and indomethacin (10 μM). (A) Cumulative concentration–response curves and (B) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4–5). ** p < 0.01, *** p < 0.001 vs. control.
Figure 3. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-incubated with NG-nitro-L-arginine methyl ester (L-NAME, 100 μM) and indomethacin (10 μM). (A) Cumulative concentration–response curves and (B) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4–5). ** p < 0.01, *** p < 0.001 vs. control.
Nutrients 15 04510 g003
Nutrients 15 04510 g004
Figure 4. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-incubated with 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 μM) and methylene blue (MB, 10 μM). (A) Cumulative concentration–response curves and (B) representative traces of aortic rings. Values are expressed as mean ± SEM (n = 4–5). *** p < 0.001 vs. control.
Figure 4. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-incubated with 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 μM) and methylene blue (MB, 10 μM). (A) Cumulative concentration–response curves and (B) representative traces of aortic rings. Values are expressed as mean ± SEM (n = 4–5). *** p < 0.001 vs. control.
Nutrients 15 04510 g004
Nutrients 15 04510 g005
Figure 5. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-incubated with barium chloride (BaCl2), 4-aminopyridine (4-AP), tetraethylammonium (TEA), or glibenclamide. (A) Cumulative concentration–response curves and (B) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4–7). *** p < 0.001 vs. control.
Figure 5. Vasorelaxant effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings pre-incubated with barium chloride (BaCl2), 4-aminopyridine (4-AP), tetraethylammonium (TEA), or glibenclamide. (A) Cumulative concentration–response curves and (B) representative traces of rat aortic rings. Values are expressed as mean ± SEM (n = 4–7). *** p < 0.001 vs. control.
Nutrients 15 04510 g005
Nutrients 15 04510 g006
Figure 6. Inhibitory effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings constricted by extracellular Ca2+. (A) Effect on extracellular CaCl2 (0.1, 0.3, 1, 3, and 10 mM) constriction and (B) representative traces of aortic rings. Values are expressed as mean ± SEM (n = 4). *** p < 0.001 vs. control.
Figure 6. Inhibitory effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings constricted by extracellular Ca2+. (A) Effect on extracellular CaCl2 (0.1, 0.3, 1, 3, and 10 mM) constriction and (B) representative traces of aortic rings. Values are expressed as mean ± SEM (n = 4). *** p < 0.001 vs. control.
Nutrients 15 04510 g006
Nutrients 15 04510 g007
Figure 7. Inhibitory effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings constricted by angiotensin II (Ang II). (A) Inhibitory effect on Ang II (10−9–10−6 M) constriction and (B) representative traces of aortic rings. Values are expressed as mean ± SEM (n = 5). ** p < 0.01 vs. Control.
Figure 7. Inhibitory effect of Sanguisorbae radix 50% ethanol extract (SRE) on rat thoracic aortic rings constricted by angiotensin II (Ang II). (A) Inhibitory effect on Ang II (10−9–10−6 M) constriction and (B) representative traces of aortic rings. Values are expressed as mean ± SEM (n = 5). ** p < 0.01 vs. Control.
Nutrients 15 04510 g007
Nutrients 15 04510 g008
Figure 8. Changes in blood pressure by Sanguisorbae radix 50% ethanol extract (SRE) administration in spontaneously hypertensive rats (SHR). (A) Systolic blood pressure (SBP), (B) diastolic blood pressure (DBP), (C) percent changes in SBP, (D) percent changes in DBP. Values are expressed as mean ± SEM (n = 5). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
Figure 8. Changes in blood pressure by Sanguisorbae radix 50% ethanol extract (SRE) administration in spontaneously hypertensive rats (SHR). (A) Systolic blood pressure (SBP), (B) diastolic blood pressure (DBP), (C) percent changes in SBP, (D) percent changes in DBP. Values are expressed as mean ± SEM (n = 5). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
Nutrients 15 04510 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jung, J.; Shin, S.; Park, J.; Lee, K.; Choi, H.-Y. Hypotensive and Vasorelaxant Effects of Sanguisorbae Radix Ethanol Extract in Spontaneously Hypertensive and Sprague Dawley Rats. Nutrients 2023, 15, 4510. https://doi.org/10.3390/nu15214510

AMA Style

Jung J, Shin S, Park J, Lee K, Choi H-Y. Hypotensive and Vasorelaxant Effects of Sanguisorbae Radix Ethanol Extract in Spontaneously Hypertensive and Sprague Dawley Rats. Nutrients. 2023; 15(21):4510. https://doi.org/10.3390/nu15214510

Chicago/Turabian Style

Jung, Jaesung, Sujin Shin, Junkyu Park, Kyungjin Lee, and Ho-Young Choi. 2023. "Hypotensive and Vasorelaxant Effects of Sanguisorbae Radix Ethanol Extract in Spontaneously Hypertensive and Sprague Dawley Rats" Nutrients 15, no. 21: 4510. https://doi.org/10.3390/nu15214510

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop